Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) EBITDA (2016 - 2025)

Harte Hanks (HHS) has disclosed EBITDA for 16 consecutive years, with $709000.0 as the latest value for Q4 2025.

  • Quarterly EBITDA rose 87.57% to $709000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.6 million through Dec 2025, down 490.91% year-over-year, with the annual reading at -$2.2 million for FY2025, 1219.39% down from the prior year.
  • EBITDA for Q4 2025 was $709000.0 at Harte Hanks, up from -$2.5 million in the prior quarter.
  • The five-year high for EBITDA was $30.6 million in Q4 2022, with the low at -$2.5 million in Q3 2025.
  • Average EBITDA over 5 years is $3.9 million, with a median of $895500.0 recorded in 2023.
  • The sharpest move saw EBITDA soared 3330.77% in 2021, then crashed 1156.78% in 2025.
  • Over 5 years, EBITDA stood at $13.3 million in 2021, then soared by 130.47% to $30.6 million in 2022, then crashed by 102.71% to -$831000.0 in 2023, then surged by 145.49% to $378000.0 in 2024, then soared by 87.57% to $709000.0 in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $709000.0, -$2.5 million, and -$218000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.